Literature DB >> 32334719

Protocols for decellularization of human amniotic membrane.

Sadjad Khosravimelal1, Maryam Momeni2, Mahdieh Gholipur3, Subhas C Kundu4, Mazaher Gholipourmalekabadi5.   

Abstract

Human amniotic membrane (HAM) has been used as a very promising biological-based product in health centers, especially for skin and cornea wound healing applications. The excellent properties of this membrane make it a potential candidate in treatment of various skin injuries such as bedsores, burn wounds and diabetic ulcers. Such properties are cytobiocompatibility, a structure very similar to normal skin composed of extracellular matrix (ECM) proteins, various growth factors involved in normal wound healing process and antibacterial agents. HAM contains epithelial cells, fibroblasts and mesenchymal stem cells. Therefore, the successful decellularization of HAM with minimal negative effects on its ECM components is very important to avoid graft rejection and shows improved performance. To date, several approaches have been conducted for decellularization of HAM, which is mainly based on enzyme-, detergent- or mechanical procedures with various ranges of success. Here, we describe a systematic detergent-based decellularization protocol as main protocol. We also explain the enzyme- and mechanical-based methods as the alternative protocols for decellularization of HAM.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amniotic membrane; Decellularization; Denudation; Detergent-based decellularization; Tissue engineering; Wound dressing

Mesh:

Year:  2019        PMID: 32334719     DOI: 10.1016/bs.mcb.2019.11.004

Source DB:  PubMed          Journal:  Methods Cell Biol        ISSN: 0091-679X            Impact factor:   1.441


  1 in total

1.  A Novel Composite Hydrogel Composed of Formic Acid-Decellularized Pepsin-Soluble Extracellular Matrix Hydrogel and Sacchachitin Hydrogel as Wound Dressing to Synergistically Accelerate Diabetic Wound Healing.

Authors:  Chien-Ming Hsieh; Weu Wang; Ying-Hsuan Chen; Pu-Sheng Wei; Yu-Hsuan Liu; Ming-Thau Sheu; Hsiu-O Ho
Journal:  Pharmaceutics       Date:  2020-06-11       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.